Physician profile
Kris Armstrong
NPI 1700861069
$3,612.29
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,438 · 2020: $913 · 2021: $877 · 2022: $246 · 2023: $123 · 2024: $14.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $868.79 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $406.41 | 2019-2021 | |
| Amarin Pharma, INC. | $347.83 | 2019-2020 | |
| Novo Nordisk INC | $307.39 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $280.87 | 2021-2022 | |
| Pfizer INC. | $234.46 | 2020-2021 | |
| Glaxosmithkline, LLC. | $228.27 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.05 | 2019-2020 | |
| Lilly USA, LLC | $170.52 | 2019-2021 | |
| Allergan, INC. | $142.18 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $124.34 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $80.15 | 2021 | |
| Abbvie INC. | $43.79 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.51 | 2019-2020 | |
| Zyla Life Sciences, INC. | $30.33 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $28.23 | 2019-2021 | |
| Sanofi Pasteur INC. | $27.75 | 2019-2020 | |
| Daiichi Sankyo INC. | $20.29 | 2019 | |
| Edwards Lifesciences Corporation | $14.72 | 2024 | |
| Merck Sharp & Dohme LLC | $13.34 | 2019 | |
| Galderma Laboratories, L.P. | $12.16 | 2019 | |
| Eisai INC. | $11.82 | 2020 | |
| Corium, LLC | $9.09 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.